» Articles » PMID: 21686139

The Prevalence and Risk Factors of Decreased Bone Mineral Density in Firstly Diagnosed Ulcerative Colitis Patients in the Eastern Region of Turkey

Overview
Specialty General Medicine
Date 2011 Jun 21
PMID 21686139
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalance of osteoporosis or osteopenia in Turkish population with ulcerative colitis (UC) at the diagnosis time has not been evaluated so far. Therefore we aimed to determine the prevelance and risk factors of decreased bone mineral density (BMD) in UC patients at the diagnosis time in Turkey. We retrospectively evaluated dexa results, demographic and clinical characteristics, and some biochemical markers of bone turnover of the UC patients at the diagnosis time between June 2005 and February 2010 from the gastroenterology clinic records of the university hospital. The study population consisted of firstly diagnosed 63 UC patients (male: female = 27: 36; mean age 41.8 years). 38.1% at lumbar spine and 44.4% at femoral neck of the Turkish UC patients patients had low BMD at the diagnosis time. The occurrence of osteoporosis among Turkish UC patients at the diagnosis time were 8% at lumbar spine and 11% at femoral neck. 30.1% at lumbar spine and 33.3% at femoral neck of the patients had osteopenia at the diagnosis time. Pearson's coefficient of correlation showed significant correlations between low BMD and pancolitis (p<0.01), age, menopause, and symptom duration before the diagnosis (p<0.05).In conclusion, the prevelance of low bone density at the diagnosis time in Turkish UC patients is in accordance with Western and Eastern societies. Pancolitis, age, duration of symptoms, and menopause are predictive factors for low bone density in these patients.

Citing Articles

Overweight and abdominal fat are associated with normal bone mineral density in patients with ulcerative colitis.

Lopes M, Lyra A, Rocha R, Coqueiro F, Lima C, de Oliveira C World J Gastrointest Pharmacol Ther. 2022; 13(4):57-66.

PMID: 36051180 PMC: 9297289. DOI: 10.4292/wjgpt.v13.i4.57.


Normal range of BMD in proximal tibia as a different skeletal site at women.

Aluclu M, Bati F, Kekilli E North Clin Istanb. 2017; 3(3):201-208.

PMID: 28275752 PMC: 5336625. DOI: 10.14744/nci.2016.95866.


Correlation analysis for follicle-stimulating hormone and C-terminal cross-linked telopetides of type i collagen in menopausal transition women with osteoporosis.

Wang B, Song Y, Chen Y, Wang E, Zheng D, Qu F Int J Clin Exp Med. 2015; 8(2):2417-22.

PMID: 25932182 PMC: 4402829.


[The decrease in bone density in chronic inflammatory bowel disease: prevalence and risk factors].

Ben Slama Trabelsi A, Abdellaoui F, Ksiaa M, Souguir A, Zeglaoui H, Rejeb M Pan Afr Med J. 2013; 15:70.

PMID: 24198872 PMC: 3809964. DOI: 10.11604/pamj.2013.15.70.2859.

References
1.
Sakellariou G, Moschos J, Berberidis C, Mpoumponaris A, Kadis S, Molyvas E . Bone density in young males with recently diagnosed inflammatory bowel disease. Joint Bone Spine. 2006; 73(6):725-8. DOI: 10.1016/j.jbspin.2006.01.017. View

2.
. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129. View

3.
Pollak R, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D . Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998; 93(9):1483-90. DOI: 10.1111/j.1572-0241.1998.468_q.x. View

4.
Tsironi E, Hadjidakis D, Mallas E, Tzathas C, Karamanolis D, Ladas S . Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients. J Musculoskelet Neuronal Interact. 2008; 8(1):79-84. View

5.
Pigot F, Roux C, Chaussade S, Hardelin D, Pelleter O, du Puy Montbrun T . Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci. 1992; 37(9):1396-403. DOI: 10.1007/BF01296010. View